Published Date: 08 Mar 2023
3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery
Read Full NewsThe Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas
All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics
Assay measures phosphorylated tau 217, an indicator of amyloid pathology
Cognitive function improved in small placebo-controlled trial
News and commentary from the world of neurology and neuroscience
At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder
In its second meeting, federal autism committee advances plan that may stymie promising research
1.
Australian researchers attribute drop in melanoma rates to increasingly diverse population
2.
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma
5.
Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment
1.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
2.
A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis
3.
Clinical Guidelines for Bone Marrow Health Monitoring in Hematologic Disorders
4.
Comprehensive Updates in Hematology and Quality Improvement
5.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Understanding Iron Deficiency and Its Common Symptoms
3.
How Cancer Screening Supports Early Diagnosis
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation